APLMW
Apollomics Inc. Warrant
$0.018+0.000 (0.000%)
Preço em tempo real
Gráfico de preços
Loading Chart...
Métricas-chave
Métricas de mercado
Abertura
$0.018
Máximo
$0.018
Mínimo
$0.018
Volume
0.00M
Fundamentos da empresa
Estatísticas de negociação
Notícias relacionadas
GlobeNewswire
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor ("EGFRi") to bring in $10 million upfront payment and expand dataset to combination therapyNew interim data for
Ver mais
GlobeNewswire
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
LaunXP receives exclusive development and commercialization rights for vebreltinib in combination with an EGFR inhibitor in Asia (excluding mainland China, Hong Kong and Macau) for the treatment of non-small cell lung
Ver mais
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.